Ge Ping

Title: Ge Ping - Innovator in Pharmaceutical Compounds

Introduction

Ge Ping is a notable inventor based in Durham, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors in the body. His work has implications for treating various central nervous system and peripheral disorders.

Latest Patents

Ge Ping holds a patent for 5-substituted-2-arylpyridines. This patent describes novel 5-substituted-2-arylpyridine compounds that act as selective modulators of CRF receptors. These compounds are particularly useful in the treatment of stress, anxiety, depression, cardiovascular disorders, and eating disorders. The patent also outlines methods of treatment for these disorders, as well as packaged pharmaceutical compositions. Additionally, the compounds can serve as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding.

Career Highlights

Ge Ping is associated with Neurogen Corporation, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in understanding and treating complex disorders that affect millions of people.

Collaborations

Ge Ping collaborates with talented individuals such as Taeyoung Yoon and Lu Yan Zhang. Their combined expertise contributes to the ongoing research and development efforts at Neurogen Corporation.

Conclusion

Ge Ping's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments that can improve the quality of life for many individuals.